Genetic Technologies Ltd (GENE) — Cash Flow Quality Index

Latest as of June 2011: 2.48x

Genetic Technologies Ltd (GENE) has a Cash Flow Quality Index of 2.48x as of June 2011. Operating cash flow of $1.12 Million exceeds net income of $450.67K, indicating high earnings quality where cash backs reported profits. Explore GENE cash flow metrics to assess how effectively this company generates cash.

Cash Flow Quality Index

2.48x
Operating CF / Net Income

Operating Cash Flow

$1.12 Million
USD

Net Income

$450.67K
USD

Data as of

Jun 2011
Most recent filing

Genetic Technologies Ltd Cash Flow Quality Index (2011–2011)

Historical Cash Flow Quality Index for Genetic Technologies Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Genetic Technologies Ltd to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Genetic Technologies Ltd (2011–2011)

Year-by-year earnings quality comparison for Genetic Technologies Ltd. For live market cap and the full company financial profile, see Genetic Technologies Ltd (GENE) market capitalisation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2011 2.48x $2.23 Million $901.34K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.